📖 Approx. 3 minutes ／ Updated 2026.06.21
In this article, an M&A advisor specializing in the healthcare industry provides a practical explanation of how mergers become a key issue in due diligence for business succession and medical M&A. We will outline specific measures based on financial, legal, labor, and clinical due diligence, as well as the determination of qualified vs. non-qualified mergers.
1. Industry Background of Merger Due Diligence
According to the Dynamic Survey of Medical Institutions by the Ministry of Health, Labour and Welfare, the business environment for medical institutions—including due diligence considerations—has become increasingly challenging in recent years due to a combination of factors such as medical fee revisions, rising labor costs, and capital investment burdens. Consequently, interest in third-party business succession M&A is growing, particularly regarding financial, legal, labor, and clinical due diligence.
At the same time, mergers are a critical consideration in medical M&A practice. Properly structuring the transaction based on whether it is classified as a qualified or non-qualified merger enables a successful succession that benefits both the seller and the buyer.
2. Key Practical Points
- Preparation: Organize the workflow, patient base, and equipment status specific to due diligence, and clarify the terms of the transfer.
- Valuation: Calculate an appropriate transfer price range based on the characteristics of the clinical specialties. In due diligence, financial, legal, labor, and clinical investigations are key to the valuation.
- Merger Structuring: Selecting the optimal scheme based on the determination of qualified vs. non-qualified mergers. Verification from tax, legal, and labor perspectives is also essential.
- Sourcing & Matching: Select prospective buyers matching the clinical specialties from a nationwide network. Carefully align the desired terms of both parties.
- Due Diligence: Conduct thorough investigations across financial, legal, labor, and clinical aspects. Verify regulatory permits and facility standards unique to healthcare due diligence.
- Final Agreement & Closing: Execute the final agreement, including representations, warranties, and indemnification clauses. Proceed with the transfer of permits and staff notifications in parallel.
3. Specific Considerations in Due Diligence
In medical institution M&A, financial, legal, labor, and clinical due diligence holds the key to a successful succession. There are numerous specific issues depending on the clinical specialty, such as the continuity of the patient base, retention of staff (physicians, nurses, and co-medicals), equipment condition and replacement plans, and the maintenance or acquisition of facility standards.
Furthermore, strategic planning based on market characteristics unique to due diligence—such as the mix of insurance-covered and self-pay services, local medical coordination networks, and relationships with competing nearby medical institutions—is crucial. Leveraging our track record in supporting successions and due diligence, we assist in practical operations from an industry-specialized perspective.
4. Practical Details of Mergers
Mergers are an area requiring highly specialized consideration in medical M&A. Structuring the transaction based on the determination of qualified vs. non-qualified mergers is the key to success.
- Review of Relevant Laws and Practical Standards: Compliance and preparation based on the Medical Service Act, tax laws, and labor regulations.
- Collaboration with Experts: Working closely with certified public accountants, tax accountants, attorneys, and labor attorneys.
- Risk Assessment: Identifying potential risks and formulating mitigation strategies.
- Consensus Building: Structuring mutually agreeable terms for both the seller and the buyer.
- Proper Documentation: Clearly defining terms in the letter of intent (LOI) and final agreement.
Frequently Asked Questions
Q. What documents are required for the initial consultation?
A. Preparing financial statements for the last three fiscal years, patient volume trends, staff composition, equipment lists, and lease agreements (if applicable) in advance will ensure a smooth process. We will collect these after executing a non-disclosure agreement (NDA).
Q. What is the typical valuation range for transactions undergoing due diligence?
A. Valuation is assessed through financial, legal, labor, and clinical due diligence. As a general guideline, clinics without beds are valued at 0.5 to 1.5 times annual revenue, while clinics with beds and hospitals are valued at 3 to 7 times EBITDA. We can provide more details through our free preliminary valuation.
Q. What should we be careful about when proceeding with a merger?
A. Prior structuring based on the determination of qualified vs. non-qualified mergers is essential. Seamless execution in collaboration with experts is the key to success.
Q. Will our staff or patients find out about the consultation?
A. Information is disclosed on a strictly limited basis after signing an NDA, and no disclosure is made to stakeholders before the final agreement. We maintain absolute confidentiality.
Related Columns
- Complete Guide to Hospital & Medical Corporation Business Succession: From Successor Shortages to Success Stories in Medical M&A Practice
- Complete Guide to Clinic Sales & Transfers: Valuation, Process, and Key Considerations Explained by Medical M&A Experts
- How to Proceed with Medical M&A and Hospital Succession: A 6-Step Guide from Consultation to Closing with Real Examples
- Complete Guide to Tax Schemes in Medical Corporation M&A: Key Issues for Tax Accountants and CPAs
Contact M&A Medical for Consultations on Merger Due Diligence
Strict Confidentiality • Free Initial Consultation • Success-Fee Based